Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...
Medical Device Network on MSN9d
Abbott eyes intravascular lithotripsy market with clinical trial approvalThe US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...
Johnson & Johnson MedTech’s Shockwave Medical is launching a new intravascular lithotripsy catheter in the U.S. that aims to clear a path through extremely narrowed or blocked blood vessels in ...
The TECTONIC Coronary Artery Disease (CAD) Intravascular Lithotripsy (IVL) clinical trial will enroll up to 335 people in 47 sites in the U.S. Coronary Artery Disease (CAD) is the most common ...
The North-Chicago based company announced today that the U.S. Food & Drug Administration gave investigational device exemption to Abbott's coronary intravascular lithotripsy system. The trial will ...
A patient-reported outcomes trial used the ICIQ-S to compare patient experiences and satisfaction after ureteroscopy with placement of a silicone or polyurethane stent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback